{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "LRRK2",
        "Protein_Change": {
          "ref": "R",
          "alt": "C",
          "position": "1441"
        },
        "variant_string_id": "LRRK2 R1441C"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "LRRK2 is the gene responsible for autosomal-dominant PD, PARK8.",
          "judgment": "Yes",
          "reasoning": "The paper establishes LRRK2 as the causal gene for Parkinson's disease, providing the foundation for understanding the disease mechanism."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study used protein kinase assays and pull-down assays to investigate LRRK2 function.",
          "judgment": "Yes",
          "reasoning": "Protein kinase assays and pull-down assays are relevant to understanding LRRK2 function, as they assess protein interactions and phosphorylation activity, which are crucial for kinase-related diseases.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "The paper does not explicitly state the number of replicates or if both wild-type and abnormal controls were used in each specific assay for this variant.",
          "judgment": "No",
          "reasoning": "The lack of detailed information regarding controls and replicates prevents a positive assessment for this sub-step.",
          "next_step_or_outcome": "Proceed to Step 3b"
        },
        {
          "step_name": "Step 3b: Accepted/Validated Assay",
          "extracted_paper_info": "Protein kinase assays and pull-down assays are established techniques in the field of biochemistry.",
          "judgment": "Yes",
          "reasoning": "These assays are standard techniques with a long history of use and acceptance within the scientific community.",
          "next_step_or_outcome": "Functional Evidence Strength: Max PS3_supporting"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The R1441C variant exhibits reduced interaction with, and phosphorylation of, Akt1, suggesting a potential mechanism for neurodegeneration. While limited control/replicate information restricts stronger evidence, established assay methods support a PS3_supporting rating."
    },
    {
      "variant_id": {
        "Gene": "LRRK2",
        "Protein_Change": {
          "ref": "G",
          "alt": "S",
          "position": "2019"
        },
        "variant_string_id": "LRRK2 G2019S"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "LRRK2 is the gene responsible for autosomal-dominant PD, PARK8.",
          "judgment": "Yes",
          "reasoning": "The paper establishes LRRK2 as the causal gene for Parkinson's disease, providing the foundation for understanding the disease mechanism."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study used protein kinase assays and pull-down assays to investigate LRRK2 function.",
          "judgment": "Yes",
          "reasoning": "Protein kinase assays and pull-down assays are relevant to understanding LRRK2 function, as they assess protein interactions and phosphorylation activity, which are crucial for kinase-related diseases.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "The paper does not explicitly state the number of replicates or if both wild-type and abnormal controls were used in each specific assay for this variant.",
          "judgment": "No",
          "reasoning": "The lack of detailed information regarding controls and replicates prevents a positive assessment for this sub-step.",
          "next_step_or_outcome": "Proceed to Step 3b"
        },
        {
          "step_name": "Step 3b: Accepted/Validated Assay",
          "extracted_paper_info": "Protein kinase assays and pull-down assays are established techniques in the field of biochemistry.",
          "judgment": "Yes",
          "reasoning": "These assays are standard techniques with a long history of use and acceptance within the scientific community.",
          "next_step_or_outcome": "Functional Evidence Strength: Max PS3_supporting"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The G2019S variant exhibits reduced interaction with, and phosphorylation of, Akt1, suggesting a potential mechanism for neurodegeneration. While limited control/replicate information restricts stronger evidence, established assay methods support a PS3_supporting rating."
    },
    {
      "variant_id": {
        "Gene": "LRRK2",
        "Protein_Change": {
          "ref": "I",
          "alt": "T",
          "position": "2019"
        },
        "variant_string_id": "LRRK2 I2019T"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "LRRK2 is the gene responsible for autosomal-dominant PD, PARK8.",
          "judgment": "Yes",
          "reasoning": "The paper establishes LRRK2 as the causal gene for Parkinson's disease, providing the foundation for understanding the disease mechanism."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study used protein kinase assays and pull-down assays to investigate LRRK2 function.",
          "judgment": "Yes",
          "reasoning": "Protein kinase assays and pull-down assays are relevant to understanding LRRK2 function, as they assess protein interactions and phosphorylation activity, which are crucial for kinase-related diseases.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "The paper does not explicitly state the number of replicates or if both wild-type and abnormal controls were used in each specific assay for this variant.",
          "judgment": "No",
          "reasoning": "The lack of detailed information regarding controls and replicates prevents a positive assessment for this sub-step.",
          "next_step_or_outcome": "Proceed to Step 3b"
        },
        {
          "step_name": "Step 3b: Accepted/Validated Assay",
          "extracted_paper_info": "Protein kinase assays and pull-down assays are established techniques in the field of biochemistry.",
          "judgment": "Yes",
          "reasoning": "These assays are standard techniques with a long history of use and acceptance within the scientific community.",
          "next_step_or_outcome": "Functional Evidence Strength: Max PS3_supporting"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The I2019T variant exhibits reduced interaction with, and phosphorylation of, Akt1, suggesting a potential mechanism for neurodegeneration. While limited control/replicate information restricts stronger evidence, established assay methods support a PS3_supporting rating."
    }
  ]
}